VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-Of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics
PLoS ONE - United States
doi 10.1371/journal.pone.0047485
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 19, 2012
Authors
Publisher
Public Library of Science (PLoS)